contract_awardAwarded Wednesday, August 5, 2026Analyzed

FLORIDA DEPARTMENT OF CHILDREN AND FAMILIES: $318M Department of Health and Human Services Grant

Neutral

Summary

The $318M grant to the Florida Department of Children and Families for opioid response is a significant state-level healthcare initiative, but as the recipient is a private entity, no publicly traded companies are directly tied. The contract supports substance abuse treatment and prevention, benefiting the healthcare sector broadly.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.The $318M grant is a state-level award with no direct public company beneficiary.
  • 2.Investors should monitor broader healthcare sector trends in substance abuse treatment.
  • 3.No specific tickers are actionable from this contract.

Market Implications

This contract has no direct market implications for publicly traded stocks. The healthcare sector may see indirect benefits from increased federal focus on opioid crisis funding, but no specific companies are positioned to gain from this award.

Full Analysis

The Substance Abuse and Mental Health Services Administration awarded a $318M project grant to the Florida Department of Children and Families for the State Opioid Response Project IV. This grant funds a comprehensive approach to opioid and stimulant misuse, including treatment, prevention, and recovery support services over three years. Since the recipient is a state agency, not a publicly traded company, no direct stock impact can be attributed. The contract underscores federal investment in behavioral health, which may indirectly benefit healthcare providers and pharmaceutical companies involved in medication-assisted treatment, but specific tickers cannot be identified without risking false positives. Related legislation, such as S5236 (Medicaid mental health services) and S5231 (removing custody limitations on benefits), aligns with the contract's goals but does not directly fund it. The contract is a routine renewal of federal opioid response funding, with moderate sector-level implications but no actionable stock catalysts.

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

proclamationJul 13, 2026

Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security

President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).

Exec OrderJun 25, 2026

Advancing Regenerative Agriculture and Strengthening American Farm Resilience

This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.

Exec OrderJun 3, 2026

Implementing Schedule Policy/Career in the Excepted Service

This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.

Contract Details

Recipient

FLORIDA DEPARTMENT OF CHILDREN AND FAMILIES

Award Amount

$317,698,497

Awarding Agency

Department of Health and Human Services

Sub-Agency

Substance Abuse and Mental Health Services Administration

Contract Type

PROJECT GRANT (B)

Related Bills

S5236S5231

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →